Pectolinarigenin Attenuates LPS-Induced Lung Inflammation and Injury with Reduced HDAC3/NF-κB/NLRP3 Signaling
Antioxidants · 20.07.2026 · 15 (7) · 898
DOI: 10.3390/antiox15070898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 20.07.2026. Verfasst von Danbee Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Research Program, Scripps Korea Antibody Institute, Chuncheon 24341, Gangwon-do, Republic of Korea. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scripps Korea Antibody Institute, Ministry of Health and Welfare, Ministry of Health & Welfare, Republic of Koreae.
Abstract (Originalsprache)
Pectolinarigenin (PEC), a naturally occurring flavonoid, exhibits anti-inflammatory and antioxidant activities in various experimental models. However, its protective effects against lipopolysaccharide (LPS)-induced lung inflammation and the underlying molecular mechanisms remain unclear. This study investigated the protective effects of PEC using LPS-treated MLE12 cells and RAW264.7 macrophages, as well as a prophylactic mouse model in which PEC was administered before LPS exposure. In LPS-treated MLE12 cells and RAW264.7 macrophages, PEC reduced inflammatory responses and cellular injury, accompanied by decreased reactive oxygen species production and modulation of the histone deacetylase 3 (HDAC3)/nuclear factor κB (NF-κB)/NOD-like receptor family pyrin domain-containing protein 3 (NLRP3) signaling. Consistent with these findings, PEC pretreatment attenuated pulmonary edema, inflammatory cell infiltration, pro-inflammatory cytokine production, oxidative stress, pyroptosis-associated signaling, and histopathological lung injury in LPS-exposed mice. These protective effects were accompanied by reduced HDAC3 expression and nuclear localization, together with reduced NF-kB/NLRP3 signaling in lung tissues. Overall, PEC attenuated LPS-induced lung inflammation and injury, accompanied by reduced oxidative stress and modulation of HDAC3/NF-κB/NLRP3 signaling. These findings support the potential of PEC as a preventive agent against excessive pulmonary inflammation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Research Program, Scripps Korea Antibody Institute, Chuncheon 24341, Gangwon-do, Republic of Korea.
- Department of Biochemistry, School of Medicine, Wonkwang University, Iksan-Daero 460, Iksan-Si 54538, Jeonbuk-Do, Republic of Korea.
ORCID-Profile: Danbee Kim, Jeong-Ran Park
Förderung
- Scripps Korea Antibody Institute
- Ministry of Health and Welfare
- Ministry of Health & Welfare, Republic of Koreae
Zitieren
APA
Kim, D., Lee, D. K., & Park, J. R. (2026). Pectolinarigenin Attenuates LPS-Induced Lung Inflammation and Injury with Reduced HDAC3/NF-κB/NLRP3 Signaling. Antioxidants, 15(7), 898. https://doi.org/10.3390/antiox15070898
Vancouver
Kim D, Lee DK, Park JR. Pectolinarigenin Attenuates LPS-Induced Lung Inflammation and Injury with Reduced HDAC3/NF-κB/NLRP3 Signaling. Antioxidants. 2026;15(7):898. doi:10.3390/antiox15070898
BibTeX
@article{Kim2026,
author = {Kim, Danbee and Lee, Dong-Keon and Park, Jeong-Ran},
title = {Pectolinarigenin Attenuates LPS-Induced Lung Inflammation and Injury with Reduced HDAC3/NF-κB/NLRP3 Signaling},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {7},
pages = {898},
doi = {10.3390/antiox15070898}
}
EUVIMED